Meghan D. Kellett

Pediatrics

3401 Civic Center Blvd
Philadelphia, PA 19104

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 4 publications

Loss of DLX3 tumor suppressive function promotes progression of SCC through EGFR-ERBB2 pathway.

Loss of DLX3 tumor suppressive function promotes progression of SCC through EGFR-ERBB2 pathway.

Journal: Oncogene

Published: December 02, 2020

A novel DLX3-PKC integrated signaling network drives keratinocyte differentiation.

A novel DLX3-PKC integrated signaling network drives keratinocyte differentiation.

Journal: Cell death and differentiation

Published: July 14, 2016

The homeoprotein DLX3 and tumor suppressor p53 co-regulate cell cycle progression and squamous tumor growth.

The homeoprotein DLX3 and tumor suppressor p53 co-regulate cell cycle progression and squamous tumor growth.

Journal: Oncogene

Published: April 03, 2015

Focal radiation therapy combined with 4-1BB activation and CTLA-4 blockade yields long-term survival and a protective antigen-specific memory response in a murine glioma model.

Focal radiation therapy combined with 4-1BB activation and CTLA-4 blockade yields long-term survival and a protective antigen-specific memory response in a murine glioma model.

Journal: PloS one

Published: March 25, 2014

Showing 1-4 of 4

Last Updated: 09/26/2026